Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

The Affiliated People's Hospital Of Ningbo University

Clinical trials sponsored by The Affiliated People's Hospital Of Ningbo University, explained in plain language.

Trials to join now! 2 Not yet recruiting 1

New drug aims to stop deadly complication in leukemia therapy

Prevention Not yet recruiting

This study tests whether the drug Lisaftoclax can prevent differentiation syndrome (DS), a severe and sometimes life-threatening side effect, in people with acute promyelocytic leukemia (APL) who are receiving standard treatment. About 60 participants aged 16 and older will take …

Phase: PHASE2, PHASE3 • Sponsor: The Affiliated People's Hospital of Ningbo University • Aim: Prevention

Last updated Jul 02, 2026 00:00 UTC